Milestone Pharmaceuticals - Common Shares (MIST) closed at $0.76 on November 6, 2026, up 10.2% from the previous close, on volume of 545,164 shares (30-day average 901,334).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 13, 2026 | Covered Call | 18-Dec-26 1.5 C +20,000 Stock | 200 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Tue, 3-Nov 8:45 PM ET)
Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026
Globe Newswire (Tue, 3-Nov 8:00 AM ET)
Globe Newswire (Mon, 2-Nov 8:00 AM ET)
Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences
Globe Newswire (Mon, 19-Oct 8:00 AM ET)
Globe Newswire (Fri, 9-Oct 8:00 AM ET)
Globe Newswire (Thu, 24-Sep 8:00 AM ET)
Globe Newswire (Thu, 3-Sep 9:35 AM ET)
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
Globe Newswire (Wed, 2-Sep 8:00 AM ET)
Globe Newswire (Thu, 27-Aug 8:00 AM ET)
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Milestone Pharmaceuticals - Common Shares trades on the NASDAQ stock market under the symbol MIST.
As of November 6, 2026, MIST stock price climbed to $0.76 with 545,164 million shares trading.
MIST has a beta of 3.28, meaning it tends to be more sensitive to market movements. MIST has a correlation of 0.22 to the broad based SPY ETF.
MIST has a market cap of $94.97 million. This is considered a Micro Cap stock.
Last quarter Milestone Pharmaceuticals - Common Shares reported $559,000 in Revenue and -$.21 earnings per share. This fell short of revenue expectation by $-254,336 and missed earnings estimates by -$.02.
In the last 3 years, MIST traded as high as $3.52 and as low as $.63.
The top ETF exchange traded funds that MIST belongs to (by Net Assets): GWX.
MIST has underperformed the market in the last year with a return of -55.7%, while the SPY ETF gained +10.8%. In the last 3 month period, MIST fell short of the market, returning -35.4%, while SPY returned -4.1%. However, in the most recent 2 weeks MIST has outperformed the stock market by returning +17.7%, while SPY returned -3.2%.
MIST support price is $.65 and resistance is $.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MIST shares will trade within this expected range on the day.
